Female Infertility

It is defined as the inability to achieve pregnancy with regular sexual intercourse for at least 12 months, and may potentially benefit from stem cell therapy. Stem cells have shown promise in restoring fertility by improving ovarian function in cases such as premature ovarian failure (POF), improving oocyte quality, and regenerating endometrial tissue in conditions such as thin endometrium or Asherman syndrome. Mesenchymal stem cells (MSCs) can enhance hormone production, support folliculogenesis, and improve implantation rates. In addition, their immunomodulatory properties could help reduce recurrent pregnancy loss, while their anti-inflammatory effects could contribute to clinical improvement in polycystic ovary syndrome.